SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: normann who wrote (1640)9/11/1998 2:09:00 PM
From: Brad  Read Replies (1) of 4650
 
Normann, I have heard the $10 to $20 range for the IPO when it ultimately happens.

But between now and then, we are looking at...

1) possible small placement of 100 to 200 thousand shares of Biomoda at $1.50 to $2.00 per share. But as I understand, the window is about to close on that because the LungCheck results are due very shortly. Then they will be looking at the $3.50 to $4.00 range per share.

2) if Biomoda is not bought out (in whole or in part), then they want to do a larger private placement of 1 million shares at about $3.50 to $4.00 per share.

3) if Biomoda develops fully on their own (without a buyout), they would do an IPO of about 1 million shares in the $10 to $20 range.

Again, that's just MY understanding from all my conversations with various sources. But the logic seems to make good sense to me.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext